[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370321-105":59,"doc-detail-370321-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lipid-metabolic-reprograming-the-unsung-hero-in-breast-cancer-progression-and-tumor-microenvironment","Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment","","Aberrant lipid metabolism is a hallmark of cancer, and breast cancer depends on a lipid-rich microenvironment that drives lipid metabolic reprogramming to meet growth requirements. This review maps the global landscape of lipid metabolism in breast cancer, linking it to tumor progression and patient prognosis. It further details lipid signaling exchanges between cancer cells and tumor microenvironment components, and summarizes therapeutic opportunities from pathway processes, lipid-related transcription factors, and immunotherapy, while outlining clinical challenges and future spatiotemporal multi-omics directions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lipid-metabolic-reprograming-the-unsung-hero-in-breast-cancer-progression-and-tumor-microenvironment/370321/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lipid-metabolic-reprograming-the-unsung-hero-in-breast-cancer-progression-and-tumor-microenvironment/370321.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does breast cancer rely on lipid metabolic reprogramming?","Question",{"text":112,"@type":113},"Breast cancer develops within a lipid-rich microenvironment and depends on lipid metabolic reprogramming to satisfy developmental requirements.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What aspects of lipid metabolism does the review cover?",{"text":117,"@type":113},"It outlines the landscape of lipid metabolism in breast cancer, including roles in progression and prognosis, lipid signaling exchanges in the tumor microenvironment, and therapeutic potential.",{"name":119,"@type":110,"acceptedAnswer":120},"How can targeting lipid metabolism be used therapeutically in breast cancer?",{"text":121,"@type":113},"The review summarizes therapeutic opportunities by focusing on lipid metabolic processes, lipid-related transcription factors, and immunotherapy approaches, then discusses clinical possibilities and problems for lipid-targeted therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370321,1790217597,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":24,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Wan etal. Molecular Cancer (2025) 24:61 Molecular Cancer  \n[https://doi.org/10.1186/s12943-025-02258-1](https://doi.org/10.1186/s12943-025-02258-1)  \n REVIEW Open Access  \nLipid metabolic reprograming: the unsung   hero in breast cancer progression and tumor microenvironment  \nMengting Wan1†, Shuaikang Pan1,3†, Benjie Shan1†, Haizhou Diao1, Hongwei Jin1,2, Ziqi Wang1, Wei Wang1,3, Shuya Han1, Wan Liu1, Jiaying He1,4, Zihan Zheng1,2, Yueyin Pan 1* , Xinghua Han 1* and Jinguo Zhang1*  \nAbstract  \nAberrant lipid metabolism is a well-recognized hallmark of cancer. Notably, breast cancer (BC) arises from a lipid-rich microenvironment and depends significantly on lipid metabolic reprogramming to fulfill its developmental requirements. In this review, we revisit the pivotal role of lipid metabolism in BC, underscoring its impact on the progression and tumor microenvironment. Firstly, we delineate the overall landscape of lipid metabolism in BC, highlighting its roles in tumor progression and patient prognosis. Given that lipids can also act as signaling molecules, we next describe the lipid signaling exchanges between BC cells and other cellular components in the tumor microenvironment. Additionally, we summarize the therapeutic potential of targeting lipid metabolism from the aspects of lipid metabolism processes, lipid-related transcription factors and immunotherapy in BC. Finally, we discuss the possibilities and problems associated with clinical applications of lipid-targeted therapy in BC, and propose new research directions with advances in spatiotemporal multi-omics.  \nKeywords Breast cancer, Lipid metabolism, Cancer progression, Tumor microenvironment, Metabolism-based therapies  \n†Mengting Wan, Shuaikang Pan and Benjie Shan contributed equally to this work.  \n*Correspondence:  \nYueyin Pan [panyueyin@ustc.edu.cn](panyueyin@ustc.edu.cn)[ ](panyueyin@ustc.edu.cn)Xinghua Han [hxhmail@ustc.edu.cn](hxhmail@ustc.edu.cn)[ ](hxhmail@ustc.edu.cn)Jinguo Zhang [Zhangjg2022@ustc.edu.cn](Zhangjg2022@ustc.edu.cn)  \n1 Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, China  \n2 School of Medical Oncology, Anhui Medical University, Hefei, China  \n3 School of Medical Oncology, Wan Nan Medical College, Wuhu, Anhui, China  \n4 Graduate School of Bengbu Medical University, Bengbu, Anhui Province, China  \nIntroduction  \nBreast cancer (BC) has emerged as the most commonly diagnosed malignancy worldwide. Representing 31% of all cancer diagnoses in women, the global incidence is anticipated to escalate by an additional 40% by the year 2040 [1]. Despite advancements in survival rates, the overall disease burden attributable to BC remains substantial, and it continues to be a predominant cause of mortality among women aged 30–60 in China [2]. BC has historically been classified into three primary subtypes based on receptor and protein expression: hormone receptor-positive (HR + , approximately 70%), HER2-positive (HER2 + , approximately 20%), and triple-negative (approximately 10%). Each subtype exhibits distinct clinical and molecular characteristics, necessitating tailored diagnostic and therapeutic strategies [3, 4]. Recent advancements in molecular biology have facilitated the  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless ind","cbCaimLpFWojciV3","https://ap.wps.com/l/cbCaimLpFWojciV3","pdf",3620976,44,"English","# Abstract\n# Introduction\n## Breast cancer epidemiology and molecular subtypes\n## Advances in prognosis tools and tumor microenvironment targeting\n# Metabolic reprogramming and lipid metabolism basics\n# Lipid metabolic reprogramming in breast cancer progression and TME","[{\"question\":\"Why does breast cancer rely on lipid metabolic reprogramming?\",\"answer\":\"Breast cancer develops within a lipid-rich microenvironment and depends on lipid metabolic reprogramming to satisfy developmental requirements.\"},{\"question\":\"What aspects of lipid metabolism does the review cover?\",\"answer\":\"It outlines the landscape of lipid metabolism in breast cancer, including roles in progression and prognosis, lipid signaling exchanges in the tumor microenvironment, and therapeutic potential.\"},{\"question\":\"How can targeting lipid metabolism be used therapeutically in breast cancer?\",\"answer\":\"The review summarizes therapeutic opportunities by focusing on lipid metabolic processes, lipid-related transcription factors, and immunotherapy approaches, then discusses clinical possibilities and problems for lipid-targeted therapy.\"}]","Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment | PDF",1790187974,111,[147,151,155,159,163],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7c1bff60f7e185a995308fe75334fb3.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b7df1c7904416aef8385ccd5d330809.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f77df2c36f1ffa47a28cb104b8eae76.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/776eb05ab2b54514338af3dfc9b319b0.webp",980,1301,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95f717b66ed3ad21084fd8db2dc4f5a6.webp",979,1300]